IndiaTickerLatest filing: Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
ObservedCompany dossier
Sun Pharmaceutical
NSE:SUNPHARMA · ISIN INE044A01036
- Close
- ₹1,989.9 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Sun Pharmaceutical
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Mar 2026 · revenue ₹14,611.8 Cr · PAT ₹2,709.7 Cr.
Exchange XBRLLatest ownership: promoter group 54.48% and public 45.52% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
BSE · exchange filing
Observed
Source filing Press Release - Sun Pharmaceutical Industries Limited
NSE · exchange filing
Observed
Source filing Copy of Newspaper Publication - Sun Pharmaceutical Industries Limited
NSE · exchange filing
Observed
Source filing Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Reported financials
Full financials →31 Mar 2026
- Revenue from operations
- ₹14,611.8 Cr
- Profit after tax
- ₹2,709.7 Cr
- EPS
- ₹11.30
Observed BSE structured filing · consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 54.48%
- Public
- 45.52%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL